Why attend?
Our comprehensive education program offers cutting-edge technical sessions, shedding light on the latest advancements in areas like supply chain, operations, facilities, and regulatory affairs, but also emphasizing the role of data science including model-informed drug development (MIDD) and technology in shaping the future of product development, production systems, and quality assurance.
This signature gathering is not just an opportunity to learn but also to connect. From emerging talents to seasoned executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies, attendees will get the chance to network, exchange insights, and preview the latest technologies and services at our expansive Partner Showcase.
Your Conference Experience
However you choose to attend, ISPE provides you with the best means to connect, learn, and grow your career.
Networking Events
Networking Events
Immerse yourself in an evening of unparalleled networking, delicious food, refreshing drinks, and engaging activities at The House of Blues.
Professional Training
Professional Training
Courses present exercises that use current problems and situations common to the industry.
Keynote Speakers
Keynote Speakers
Subject matter experts and top leaders in the pharmaceutical industry
Regulatory Town Hall
Regulatory Town Hall
Engage in a constructive and productive dialogue on charting the direction for innovation in the industry.
44
+
Education Hours
16
+
Networking Hours
250
+
220+ Exhibitors
220
+
Exhibitors
Conference Highlights
Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP (Emerging Technology Program), and the European Medicines Agency (EMA) with the Quality Innovation Group (QIG). There are also ongoing collaborative initiatives such as Orbis, ACCESS, and the International Coalition of Medicines Regulatory Authorities (ICMRA) that exemplify the effort of health authorities to provide potentially faster access to medicines for patients around the world.
Practice the ISPE Good Practice Guide Series – Expert Workshops at the 2024 ISPE Annual Meeting & Expo
Building off the success of the 2023 ISPE Annual Meeting & Expo, the program committee has developed a robust workshop program, taking place Sunday, 13 October, which is based on the practical application of the ISPE Baseline Guide and ISPE Good Practice Guide (GPG) Series, covering the following key areas:
ISPE Annual Meeting & Expo Gallery
International Program Committee
Senior Director and Group Manager, Project and Product Leadership
AstraZeneca
Head of Operations Quality, Compliance and External Affairs
AstraZeneca
Chief Executive Officer
Seeq Corporation
Retired, Computer Systems Quality & Data Integrity
Vice-President and General Manager, Life Sciences
Jacobs
Manager, Biotherapeutic Quality Division
Health Canada
Senior Director, Consulting Services
CRB
Senior Director, Quality Operations/Environmental Health & Safety
Pfizer
Director
No Deviation Pte Ltd
Senior Director, Manufacturing Science and Technology
Johnson & Johnson
Director, Digital Solutions
Performance Validation
Director
WakeUp To Quality
Senior Director, Compliance Consulting
IPS – Integrated Project Services, LLC
Executive Industry Advisor
Körber Pharma Software GmbH
Manager, Clinical Supply Chain Operations
Biomarin
Operational Excellence Engineer
Thermo Fisher Scientific
Process Engineer II
Genesis AEC
Operations Lead and Start-up Manager
AstraZeneca
Quality Assurance, R&D Clinical Injectable Manufacturing
Sanofi